Publikationen der ALS-Forschungsgruppe an der Charité Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in GermanySpittel S, Maier A, Kettemann D, Mehr Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in Germany Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme .Meyer T, Kettemann D, Maier A, Mehr Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme . Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spastic using tetrahydrocannabinol:cannabidiol (THC:CBD).Meyer T, Funke A, Münch C, Mehr Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spastic using tetrahydrocannabinol:cannabidiol (THC:CBD). Patient-Reported Outcome of Physical Therapy in Amyotrophic Lateral Sclerosis: Observational Online StudyMeyer R, Spittel S, Steinfurth L, Mehr Patient-Reported Outcome of Physical Therapy in Amyotrophic Lateral Sclerosis: Observational Online Study Provision of assistive technology devices among peolple with ALS in Germany: a platform-case management approach.Funke A, Spittel S, Grehl T, Mehr Provision of assistive technology devices among peolple with ALS in Germany: a platform-case management approach. Clinical characteristics and course of dying in patients with amyotrophic lateral sclerosis withdrawing from long-term ventilation.Kettemann D, Funke A, Maier A, Mehr Clinical characteristics and course of dying in patients with amyotrophic lateral sclerosis withdrawing from long-term ventilation. 1 2 3 … 5 Weiter » Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis.Ludolph AC, Dorst J, Dreyhaupt J, Mehr Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis. Prognostic factors in ALS: a comparison between Germany and China.Dorst J, Chen L, Rosenbohm A, Mehr Prognostic factors in ALS: a comparison between Germany and China. GABAB receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis.Schumacher H, Meyer T, Prüss H.BMC Mehr GABAB receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialLudolph AC, Schuster J, Dorst J, Mehr Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial Comprehensive analysis of the mutation spectrum in 301 German ALS families.Müller K, Brenner D, Weydt P, Mehr Comprehensive analysis of the mutation spectrum in 301 German ALS families. Therapeutic decision in ALS patients: cross-cultural differences and clinical implications.Andersen PM, Kuzma-Kozakiewicz M, Keller J, Mehr Therapeutic decision in ALS patients: cross-cultural differences and clinical implications. 1 2 3 … 8 Weiter »
